CSNK1A1 and posterior cortical atrophy: The genetic alteration frequency of CSNK1A1 in PCa is lower than that of other therapeutically relevant genes, such as PRKDC, and the percentage of structural alterations is similar for metastatic and primary PCa (Figure 6).